| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/17/2012 | CA2558139C Tricyclic benzopyran compound as anti-arrhythmic agents |
| 01/12/2012 | WO2012006584A2 Therapeutic regimens for hedgehog-associated cancers |
| 01/12/2012 | WO2012006055A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
| 01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
| 01/12/2012 | WO2012004400A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/12/2012 | WO2012004378A1 Spiro-cyclic amine derivatives as s1p modulators |
| 01/12/2012 | WO2012004373A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | WO2012004217A1 Cyclic ether compounds useful as kinase inhibitors |
| 01/12/2012 | WO2012004206A1 Anellated pyridine compounds |
| 01/12/2012 | US20120010229 Therapeutic regimens for hedgehog-associated cancers |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010220 Spiroindolinepiperidine derivatives |
| 01/12/2012 | US20120010204 Phthalazinone Derivatives |
| 01/12/2012 | US20120010193 Cgrp receptor antagonists |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | CA2804143A1 Spiro-cyclic amine derivatives as s1p modulators |
| 01/12/2012 | CA2804137A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | CA2803248A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | CA2801583A1 Anellated pyridine compounds |
| 01/12/2012 | CA2800930A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/11/2012 | EP2404922A1 Quinoxaline compounds |
| 01/11/2012 | EP2403856A1 Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer |
| 01/11/2012 | EP2403844A1 Heterocyclic antiviral compounds |
| 01/11/2012 | EP1945647B1 Processes for preparation of maytansinol |
| 01/11/2012 | EP1486549B1 Organic electroluminescent element |
| 01/11/2012 | CN1761660B Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311443A Novel crystal form of irinotecan hydrochloride and preparation method thereof |
| 01/11/2012 | CN102311442A Spirolactam alkaloid compound with anti-tumor activity and preparation method as well as application thereof |
| 01/11/2012 | CN102311367A Benzylamine derivative and application thereof in galanthamine synthesis |
| 01/11/2012 | CN101602767B Preparation method of galanthamine |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/11/2012 | CN101077872B Method for preparing etodolac methyl ester |
| 01/10/2012 | US8093288 Genipin derivatives and uses thereof |
| 01/10/2012 | US8093257 [6,5]-bicyclic GPR119 G protein-coupled receptor agonists |
| 01/10/2012 | US8093254 Aspartyl protease inhibitors |
| 01/10/2012 | CA2578767C Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin |
| 01/05/2012 | WO2012003283A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | US20120004422 Intermediates Useful in the Preparation of Maleimide Functionalized Polymers |
| 01/05/2012 | US20120004255 Dual phase drug release system |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004223 Compounds, compositions and methods for reducing lipid levels |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/04/2012 | EP2402347A1 Pharmaceutical compounds |
| 01/04/2012 | EP2402314A1 (Aza)indole derivative and use thereof for medical purposes |
| 01/04/2012 | EP2401280A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 01/04/2012 | EP2401266A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401262A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401255A1 Catecholamine derivatives and prodrugs thereof |
| 01/04/2012 | EP1833827B9 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 01/04/2012 | CN1926107B Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions |
| 01/04/2012 | CN102307878A 3,6-disubstituted xanthylium salts |
| 01/04/2012 | CN102304132A High-efficiency high-stereoselectivity semisynthesis method of harringtonine and allied alkaloids |
| 01/04/2012 | CN102304131A Triprenyl phenol compound and thrombolysis enhancer |
| 01/04/2012 | CN102304031A Benzaldehyde derivative and use thereof in preparation of galanthamine |
| 01/04/2012 | CN101787028B Method for extracting galanthamine from lycoris aurea |
| 01/04/2012 | CN101367821B Preparation method of tetrodotoxin for high purity medicine source monomer |
| 01/03/2012 | US8088935 Compounds and methods for the treatment of asthma |
| 01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 01/03/2012 | US8088918 Noncardiotoxic pharmaceutical compounds |
| 01/03/2012 | US8088917 Ionic liquids |
| 01/03/2012 | US8088792 Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors |
| 01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
| 01/03/2012 | CA2548543C Process for making camptothecin derivatives |
| 01/03/2012 | CA2494183C Processes for preparing 1,3-dioxolane nucleosides |
| 12/29/2011 | WO2011162368A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 12/29/2011 | WO2011162364A1 Noxious arthropod control composition, and heterocyclic compound |
| 12/29/2011 | WO2011161009A1 Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors |
| 12/29/2011 | US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110318788 Multisignal labeling reagents and processes and uses therefor |
| 12/29/2011 | CA2792966A1 Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors |
| 12/28/2011 | EP2399919A1 (S)-4,11-diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano [3',4':6,7] indolizino [1.2-b]quinoline-4,9-diyl bis([1,4'-bipiperidine]-carboxylate and its use |
| 12/28/2011 | EP2399908A1 Polymorphic form of 7-ethyl-10[4-(1-piperidino)-1- piperidino]carbonyloxy- camptothecin and its use |
| 12/28/2011 | EP2398809A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 12/28/2011 | EP2398790A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 12/28/2011 | CN101550103B 1,2,3,4-四氢异喹啉衍生物及其合成方法和用途 1,2,3,4-tetrahydroisoquinoline derivatives and synthetic method and use |
| 12/28/2011 | CN101495484B 具有抗肿瘤活性的喜树碱衍生物 Camptothecin derivatives have anti-tumor activity |
| 12/27/2011 | US8084603 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors |
| 12/22/2011 | WO2011159903A2 Asenapine maleate |
| 12/22/2011 | WO2011159177A1 Improved aminohydroxylation of alkenes |
| 12/22/2011 | WO2011158833A1 Agent for treating hcv infection |
| 12/22/2011 | WO2011157682A1 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators |
| 12/22/2011 | WO2011157346A1 Compounds for electronic devices |
| 12/22/2011 | US20110313151 Anellated pyridine compounds |
| 12/22/2011 | US20110313002 Tricyclic compounds |
| 12/22/2011 | US20110312952 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 12/22/2011 | US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof |
| 12/22/2011 | US20110311482 Hepatitis C Virus Inhibitors |
| 12/22/2011 | CA2802990A1 Asenapine maleate |
| 12/22/2011 | CA2802477A1 Agent for treating hcv infection |
| 12/22/2011 | CA2801168A1 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators |